By Counterforce Health Team in Soliris (eculizumab) —

Do You Qualify for Soliris (Eculizumab) Coverage by Aetna CVS Health in Texas? Decision Tree & Next Steps

Answer Box: Your Path to Soliris Coverage in Texas

Likely eligible if you have PNH with flow cytometry showing ≥10% clones plus LDH ≥1.5x normal, aHUS with documented TMA (excluding STEC), anti-AChR positive myasthenia gravis with failed immunosuppressants, or AQP4-positive NMOSD. Required first step: Complete meningococcal vaccination ≥2 weeks before treatment and ensure your prescriber enrolls in the Soliris REMS program. Submit the Aetna Soliris Precertification Request Form via CVS Specialty Pharmacy. If denied, Texas law guarantees external review through an Independent Review Organization within 120 days.

Table of Contents

  1. How to Use This Decision Tree
  2. Eligibility Triage: Do You Qualify?
  3. If "Likely Eligible": Your Action Plan
  4. If "Possibly Eligible": Tests and Timeline
  5. If "Not Yet": Alternative Paths
  6. If Denied: Texas Appeal Process
  7. Common Denial Reasons & Solutions
  8. Cost Assistance Programs
  9. FAQ: Texas-Specific Questions

How to Use This Decision Tree

This guide helps patients and clinicians navigate Aetna CVS Health's prior authorization process for Soliris (eculizumab) in Texas. Start with the eligibility triage below, then follow the corresponding action plan. Each section includes specific forms, deadlines, and contact information verified with official sources.

Note: Aetna requires all Soliris prescriptions to go through CVS Specialty Pharmacy, and prescribers must be enrolled in the FDA REMS program before any coverage determination.

Eligibility Triage: Do You Qualify?

Likely Eligible ✅

Paroxysmal Nocturnal Hemoglobinuria (PNH)

  • Flow cytometry confirming ≥10% PNH clones with ≥2 GPI protein deficiencies
  • LDH ≥1.5x upper limit of normal
  • Symptomatic disease (hemoglobin <10 g/dL, thrombosis, organ damage, or disabling fatigue)

Atypical Hemolytic Uremic Syndrome (aHUS)

  • Signs of thrombotic microangiopathy with platelets <150,000
  • LDH >2x upper limit normal, elevated creatinine
  • STEC-HUS and TTP ruled out (ADAMTS13 activity ≥10%)

Generalized Myasthenia Gravis (gMG)

  • Positive anti-AChR antibodies
  • MG-ADL score ≥5
  • Failed ≥2 immunosuppressive therapies over 12 months

Neuromyelitis Optica Spectrum Disorder (NMOSD)

  • Positive AQP4 antibodies
  • ≥2 relapses in 12 months or ≥3 in 24 months
  • EDSS ≤7.0

Possibly Eligible ⚠️

  • Diagnosis suspected but missing key lab confirmations
  • Some but not all step therapy requirements met
  • Clinical documentation incomplete

Not Yet ❌

  • Diagnosis not confirmed with required testing
  • STEC-HUS not excluded for aHUS cases
  • Missing meningococcal vaccination records
  • No documented failures of required prior therapies (gMG)

If "Likely Eligible": Your Action Plan

Step 1: Complete REMS Requirements (2-4 weeks before treatment)

  1. Prescriber enrollment: Your doctor must register at ultsolrems.com or call 1-888-765-4747
  2. Meningococcal vaccination: Complete MenACWY and MenB series ≥2 weeks before first dose
  3. Patient counseling: Receive REMS Patient Guide and Safety Card from certified prescriber

Step 2: Gather Required Documentation

All indications need:

  • Current labs within 30 days
  • ICD-10 diagnosis codes
  • Weight-based dosing calculations
  • Vaccination records
  • Treatment goals and expected duration

Condition-specific requirements:

Condition Required Tests Additional Documentation
PNH Flow cytometry, LDH, CBC Transfusion history, hemolysis symptoms
aHUS Platelet count, LDH, creatinine ADAMTS13 results, STEC exclusion
gMG Anti-AChR antibodies, MG-ADL score Prior immunosuppressant trials (≥12 months)
NMOSD AQP4 antibodies, MRI Relapse history, EDSS score

Step 3: Submit Prior Authorization

Step 4: CVS Specialty Pharmacy Coordination

Once approved, Aetna requires dispensing through CVS Specialty Pharmacy. They'll coordinate with your infusion center for delivery and administration scheduling.

If "Possibly Eligible": Tests and Timeline

Missing Lab Work

Order these tests before resubmitting:

  • PNH: Flow cytometry for GPI-anchored proteins on blood cells
  • aHUS: ADAMTS13 activity, Shiga toxin testing
  • gMG: Anti-AChR antibody titers, quantitative myasthenia gravis score
  • NMOSD: AQP4-IgG antibodies, brain/spinal MRI

Incomplete Step Therapy (gMG only)

Document trials of these agents with dates, dosages, and reasons for discontinuation:

  • Azathioprine, corticosteroids, cyclosporine, methotrexate, mycophenolate, or tacrolimus
  • Each trial should be ≥3 months unless discontinued for intolerance

Timeline to reapply: 2-4 weeks after obtaining missing documentation

If "Not Yet": Alternative Paths

Request Medical Necessity Exception

If you don't meet standard criteria, your doctor can request an exception by demonstrating:

  • Unique clinical circumstances
  • Contraindications to required prior therapies
  • Urgent medical need

Consider Biosimilar Alternatives

Two eculizumab biosimilars follow the same PA requirements but may have different coverage tiers:

  • Eculizumab-aeeb (Bkemv) - interchangeable with Soliris
  • Eculizumab-aagh (Epysqli)

Alternative Medications by Indication

Condition Alternative Options
PNH Ultomiris (ravulizumab), Empaveli (pegcetacoplan), Crovalimab (Piasky)
gMG Vyvgart (efgartigimod), Zilbrysq (zilucoplan)
NMOSD Enspryng (satralizumab), Uplizna (inebilizumab)

If Denied: Texas Appeal Process

Texas provides robust patient protections for specialty drug denials. Here's your step-by-step appeal path:

Internal Appeals (Required First Step)

Level 1 Appeal

Level 2 Appeal

  • Deadline: 60 days from Level 1 denial
  • Timeline: 30-60 days for decision
  • Reviewer: Different medical director than Level 1

Expedited Appeals (Urgent Cases)

  • Timeline: 72 hours for decision
  • Eligibility: Life-threatening conditions or drugs you're currently receiving
  • How to request: Note "expedited" on appeal form and provide clinical justification

External Review (Texas IRO Process)

After exhausting internal appeals, Texas law provides binding external review:

Eligibility Requirements:

  • Final internal denial based on medical necessity
  • Financial responsibility exceeds $500
  • Treatment isn't experimental/investigational

Timeline:

  • File within: 120 days of final internal denial
  • Decision time: 20 days (standard) or 72 hours (expedited)
  • Cost: Free to patient (insurer pays IRO)

How to Request:

  1. Complete IRO request form provided with final denial
  2. Submit to Texas Department of Insurance
  3. Include all medical records and denial letters
From our advocates: We've seen Soliris appeals succeed most often when the submission includes peer-reviewed studies supporting the specific indication, detailed documentation of prior treatment failures, and a comprehensive letter from the treating specialist explaining why alternatives aren't appropriate. The key is addressing each denial reason point-by-point with clinical evidence.

Common Denial Reasons & Solutions

Denial Reason Solution Required Documentation
"Diagnosis not confirmed" Submit definitive lab results Flow cytometry report, antibody titers
"Step therapy not met" (gMG) Document prior failures Pharmacy records, clinic notes, intolerance details
"Not medically necessary" Provide clinical rationale Specialist letter, peer-reviewed studies, guidelines
"REMS not completed" Complete enrollment REMS confirmation, vaccination records
"Experimental/investigational" Cite FDA approval FDA label, clinical guidelines, published studies

Cost Assistance Programs

Manufacturer Support:

  • Alexion OneSource: Patient assistance program and copay support
  • Financial eligibility based on income and insurance type

Foundation Grants:

  • Patient Access Network Foundation
  • HealthWell Foundation
  • National Organization for Rare Disorders (NORD)

Texas-Specific Resources:

  • Texas Department of Insurance consumer helpline: 1-800-252-3439
  • Office of Public Insurance Counsel: 1-877-611-6742

FAQ: Texas-Specific Questions

Q: How long does Aetna CVS Health prior authorization take in Texas? A: Standard reviews take 5-15 business days. Expedited reviews for urgent cases are completed within 72 hours.

Q: Can I appeal if my employer plan is self-funded? A: Self-funded ERISA plans follow federal appeal rules, not Texas state law. You'll still have internal appeal rights, but external review may go through a different process.

Q: What if Soliris isn't on Aetna's formulary? A: Request a formulary exception with your appeal. Include medical necessity documentation and evidence that formulary alternatives aren't appropriate.

Q: Does step therapy apply if I failed therapies outside Texas? A: Yes, documented treatment failures from any state count toward step therapy requirements. Include pharmacy records and clinic notes from previous providers.

Q: Can I get emergency coverage while appealing? A: Texas law requires insurers to provide 72-hour emergency supplies during renewal delays. For new prescriptions, request expedited appeals with clinical urgency documentation.

Q: What counts as "medical necessity" for Soliris? A: Treatment must be consistent with FDA labeling, supported by clinical guidelines, and appropriate for your specific diagnosis and clinical circumstances.

Counterforce Health specializes in turning insurance denials into successful appeals by analyzing denial letters, plan policies, and clinical notes to create targeted, evidence-backed responses. Their platform helps patients and clinicians navigate complex prior authorization requirements and appeal processes for specialty medications like Soliris.

Sources & Further Reading

Disclaimer: This information is for educational purposes only and does not constitute medical or legal advice. Coverage decisions vary by individual plan and clinical circumstances. Always consult with your healthcare provider and insurance plan for specific guidance regarding your situation. For assistance with appeals and prior authorizations, consider consulting with Counterforce Health or other qualified advocacy services.

Powered by Counterforce Health—AI that turns drug denials into evidence-based appeals patients and clinicians can submit today.